^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

C-CAR011

i
Other names: C-CAR011, anti-CD19-CAR vector-transduced T cells, anti-CD19 chimeric antigen receptor T cell therapy, CD19 specific CART cells , CART-19, CBM.CD19-targeted chimeric antigen receptor T cells
Associations
Trials
Company:
AbelZeta Pharma, Chinese PLA General Hospital
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials